Could Veeva or Medidata add CTCAE grading as a feature?

Veeva and Medidata sit downstream of the attribution decision: they capture what the clinician decided. Burna AI sits upstream: it helps the investigator make the attribution decision at the point of clinical encounter. That is the white space. No EDC platform helps the investigator reason about which drug in a three-drug regimen most likely caused the Grade 3 hepatitis. The architectural posture, the patents, and the named algorithms with visible math are not a feature that gets added; they are a category.